Cargando…

Pre-Gestational Diabetes and Pregnancy Outcomes

INTRODUCTION: Pre-gestational, type 1 and type 2 diabetes are associated with adverse neonatal outcomes and increased rates of emergency caesarean sections. METHODS: We studied pregnancy outcomes associated with pre-gestational diabetes in 174 women who attended the National Maternity Hospital in Du...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Dalal S., Davern, Recie, Rutter, Eimear, Coveney, Ciara, Devine, Hilary, Walsh, Jennifer M., Higgins, Mary, Hatunic, Mensud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644712/
https://www.ncbi.nlm.nih.gov/pubmed/33010001
http://dx.doi.org/10.1007/s13300-020-00932-9
_version_ 1783606511177564160
author Ali, Dalal S.
Davern, Recie
Rutter, Eimear
Coveney, Ciara
Devine, Hilary
Walsh, Jennifer M.
Higgins, Mary
Hatunic, Mensud
author_facet Ali, Dalal S.
Davern, Recie
Rutter, Eimear
Coveney, Ciara
Devine, Hilary
Walsh, Jennifer M.
Higgins, Mary
Hatunic, Mensud
author_sort Ali, Dalal S.
collection PubMed
description INTRODUCTION: Pre-gestational, type 1 and type 2 diabetes are associated with adverse neonatal outcomes and increased rates of emergency caesarean sections. METHODS: We studied pregnancy outcomes associated with pre-gestational diabetes in 174 women who attended the National Maternity Hospital in Dublin, Ireland, between 2015 and 2017. RESULTS: Fifty women (28.6%) had type 2 diabetes mellitus, and 124 women (71.4%) had type 1 diabetes mellitus. Women with type 2 diabetes mellitus were older (36 vs. 34 years, p 0.02) and had a higher BMI (32.6 vs. 26.2 kg/m(2), p 0.00). Duration of diabetes mellitus in type 1 and type 2 was 15.7 and 5.7 years, respectively, and mean HbA1c in type 2 diabetes mellitus at booking was 44.5 mmol/mol (6.2%) and in type 1 diabetes mellitus was 56.3 mmol/mol (7.3%). Forty women (32%) with type 1 diabetes mellitus used continuous subcutaneous insulin infusion. In our cohort, 45.4% had a caesarean delivery. Offspring of patients with multiple dose injections were lighter (3.58 kg) than infants of continuous subcutaneous insulin infusion-treated patients (3.75 kg). More emergency caesarean sections were observed in the continuous subcutaneous insulin infusion group than in the group treated with multiple dose injections (37.5% vs. 28.5%), while the elective caesarean section rate was higher in the multiple dose injection group (17.8% vs. 12.5%). Women treated with continuous subcutaneous insulin infusion had a higher rate of miscarriage (25% vs. 19%) with more congenital malformations (10% vs. 2.3%). CONCLUSIONS: Women in our study with pre-gestational diabetes were overweight, were older and had long-standing diabetes mellitus. Our patients with type 2 diabetes had a higher BMI, were older, had a shorter duration of diabetes mellitus and had better diabetes control compared to women with type 1 diabetes. Women treated with continuous subcutaneous insulin infusion had a higher rate of miscarriage with more congenital malformations. The initial inadequate diabetes control was significantly improved during pregnancy.
format Online
Article
Text
id pubmed-7644712
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-76447122020-11-10 Pre-Gestational Diabetes and Pregnancy Outcomes Ali, Dalal S. Davern, Recie Rutter, Eimear Coveney, Ciara Devine, Hilary Walsh, Jennifer M. Higgins, Mary Hatunic, Mensud Diabetes Ther Original Research INTRODUCTION: Pre-gestational, type 1 and type 2 diabetes are associated with adverse neonatal outcomes and increased rates of emergency caesarean sections. METHODS: We studied pregnancy outcomes associated with pre-gestational diabetes in 174 women who attended the National Maternity Hospital in Dublin, Ireland, between 2015 and 2017. RESULTS: Fifty women (28.6%) had type 2 diabetes mellitus, and 124 women (71.4%) had type 1 diabetes mellitus. Women with type 2 diabetes mellitus were older (36 vs. 34 years, p 0.02) and had a higher BMI (32.6 vs. 26.2 kg/m(2), p 0.00). Duration of diabetes mellitus in type 1 and type 2 was 15.7 and 5.7 years, respectively, and mean HbA1c in type 2 diabetes mellitus at booking was 44.5 mmol/mol (6.2%) and in type 1 diabetes mellitus was 56.3 mmol/mol (7.3%). Forty women (32%) with type 1 diabetes mellitus used continuous subcutaneous insulin infusion. In our cohort, 45.4% had a caesarean delivery. Offspring of patients with multiple dose injections were lighter (3.58 kg) than infants of continuous subcutaneous insulin infusion-treated patients (3.75 kg). More emergency caesarean sections were observed in the continuous subcutaneous insulin infusion group than in the group treated with multiple dose injections (37.5% vs. 28.5%), while the elective caesarean section rate was higher in the multiple dose injection group (17.8% vs. 12.5%). Women treated with continuous subcutaneous insulin infusion had a higher rate of miscarriage (25% vs. 19%) with more congenital malformations (10% vs. 2.3%). CONCLUSIONS: Women in our study with pre-gestational diabetes were overweight, were older and had long-standing diabetes mellitus. Our patients with type 2 diabetes had a higher BMI, were older, had a shorter duration of diabetes mellitus and had better diabetes control compared to women with type 1 diabetes. Women treated with continuous subcutaneous insulin infusion had a higher rate of miscarriage with more congenital malformations. The initial inadequate diabetes control was significantly improved during pregnancy. Springer Healthcare 2020-10-03 2020-12 /pmc/articles/PMC7644712/ /pubmed/33010001 http://dx.doi.org/10.1007/s13300-020-00932-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Ali, Dalal S.
Davern, Recie
Rutter, Eimear
Coveney, Ciara
Devine, Hilary
Walsh, Jennifer M.
Higgins, Mary
Hatunic, Mensud
Pre-Gestational Diabetes and Pregnancy Outcomes
title Pre-Gestational Diabetes and Pregnancy Outcomes
title_full Pre-Gestational Diabetes and Pregnancy Outcomes
title_fullStr Pre-Gestational Diabetes and Pregnancy Outcomes
title_full_unstemmed Pre-Gestational Diabetes and Pregnancy Outcomes
title_short Pre-Gestational Diabetes and Pregnancy Outcomes
title_sort pre-gestational diabetes and pregnancy outcomes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644712/
https://www.ncbi.nlm.nih.gov/pubmed/33010001
http://dx.doi.org/10.1007/s13300-020-00932-9
work_keys_str_mv AT alidalals pregestationaldiabetesandpregnancyoutcomes
AT davernrecie pregestationaldiabetesandpregnancyoutcomes
AT ruttereimear pregestationaldiabetesandpregnancyoutcomes
AT coveneyciara pregestationaldiabetesandpregnancyoutcomes
AT devinehilary pregestationaldiabetesandpregnancyoutcomes
AT walshjenniferm pregestationaldiabetesandpregnancyoutcomes
AT higginsmary pregestationaldiabetesandpregnancyoutcomes
AT hatunicmensud pregestationaldiabetesandpregnancyoutcomes